Neonc Technologies Holdings, Inc.
Neonc Technologies Holdings, Inc.
Your view on NTHI
Overview
What the company does, where it operates, and who runs it.
About Neonc Technologies Holdings, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Amir Farrokh Heshmatpour
- Headquarters
- US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Amir Farrokh Heshmatpour
- Headquarters
- US
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases.
Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
Fair value for Neonc Technologies Holdings, Inc. from FRC's valuation model, read against the market price. NTHI last traded at $4.37; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Neonc Technologies Holdings, Inc.. Starting points for Neonc Technologies Holdings, Inc.: EPS -$1.78, beta 0.50 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Neonc Technologies Holdings, Inc.. Neonc Technologies Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Neonc Technologies Holdings, Inc.. Trailing twelve-month EPS for Neonc Technologies Holdings, Inc. stands at -$1.78. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Neonc Technologies Holdings, Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Neonc Technologies Holdings, Inc. valued side by side against its closest peers. Neonc Technologies Holdings, Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Neonc Technologies Holdings, Inc., and how their positions are changing. At a $125.9M market value, institutional positions materially move Neonc Technologies Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Neonc Technologies Holdings, Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Neonc Technologies Holdings, Inc.. Coverage tracks Neonc Technologies Holdings, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Neonc Technologies Holdings, Inc.